YM598

DRUG2 trials

Sponsors

Astellas Pharma Inc

Conditions

Hormone-Refractory Prostate CancerProstate CancerProstatic Neoplasms

Phase 2

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

TerminatedNCT00048659

Astellas Pharma IncHormone-Refractory Prostate Cancer, Prostatic Neoplasms

End: 2004-06-30Updated: 2012-06-07

YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer

TerminatedNCT00050297

Astellas Pharma IncProstate Cancer

End: 2004-02-29Updated: 2012-06-07